Diagnos Inc.
ADK.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.60K | 16.60K | 26.80K | 31.20K | 38.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.60K | 16.60K | 26.80K | 31.20K | 38.30K |
| Cost of Revenue | 214.80K | 228.90K | 91.90K | 192.90K | 185.10K |
| Gross Profit | -196.20K | -212.30K | -65.10K | -161.80K | -146.80K |
| SG&A Expenses | 567.20K | 432.70K | 357.30K | 335.30K | 352.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 782.00K | 661.60K | 449.30K | 528.20K | 537.30K |
| Operating Income | -763.40K | -645.00K | -422.50K | -497.10K | -499.00K |
| Income Before Tax | -866.70K | -747.40K | -523.70K | -599.90K | -595.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -866.70K | -747.40K | -523.70K | -599.90K | -595.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -866.70K | -747.40K | -523.70K | -599.90K | -595.40K |
| EBIT | -763.40K | -645.00K | -422.50K | -497.10K | -499.00K |
| EBITDA | -739.90K | -621.40K | -399.20K | -492.60K | -472.60K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 93.73M | 82.35M | 77.98M | 74.95M | 72.97M |
| Average Diluted Shares Outstanding | 93.73M | 82.35M | 77.98M | 74.95M | 72.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
